111 171

Cited 0 times in

Identification of innate drug resistance against raf inhibitors in patients with papillary thyroid cancer

Other Titles
 유두상 갑상선암 환자에서 RAF 억제제의 자발적 약제내성 확인 
 College of Medicine (의과대학) 
 Dept. of Surgery (외과학교실) 
Issue Date
Recently, several novel targeted agents have been developed for treatment of BRAFV600E-positive cancers. However, de novo and acquired resistance to these agents has since emerged as a therapeutic obstacle. Two major mechanisms, based on their dependence on RAF dimerization, drive tumor resistance to RAF inhibitors – mutations in NRAS such as NRAS Q61, the p61BRAFV600E splice variant, and C-RAF overexpression are involved in a mechanism that is dependent on RAF dimerization; in contrast, aberrant expression of Cancer Osaka Thyroid Oncogene mitogen-activated protein kinase kinase kinase 8 (COT) or mitogen-activated protein kinase kinase (MEK) mutation function independently of RAF dimerization. The aim of this study was to identify the molecular basis for innate drug resistance against RAF inhibitors in patients with papillary thyroid cancer (PTC). 167 PTC patients undergoing total thyroidectomy were enrolled. Patient information and clinicopathological parameters were analyzed. BRAFV600E mutation was included in this study. Exome sequencing for detection of mutation in NRAS and MEK was performed. For the analysis of p61BRAFV600E splice variant, DNA sequencing, Western blot and mass spectrometry were performed. CRAF overexpression and aberrant expression of COT were analyzed by quantitative polymerase chain reaction (qPCR) and immunohistochemical staining. In the results, NRAS and MEK mutation, and the p61BRAFV600E splice variant were not detected in PTC. However, qPCR data showed that the relative expression of CRAF and COT mRNA in PTC was higher than in normal tissues ( p<0.01). Furthermore, COT mRNA expression in PTC correlated positively with CRAF expression (r=0.5954, p<0.001). Immunohistochemical analysis showed that the staining intensities of COT were higher in PTC than in normal thyroid tissues (p <0.001). Aberrant expression of COT was more frequently detected in BRAFV600E-positive PTC (p=0.013). These results suggest that COT expression may be associated with innate drug resistance against RAF inhibitors in PTC.
Files in This Item:
TA02068.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 3. Dissertation
Yonsei Authors
Park, Jae Hyun(박재현)
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.